Who owns Alimera Sciences Inc?
- Ticker: ALIM
- CUSIP Number: 016259202
Tip: Access positions for across all investors
Analyze quarterly positions in Alimera Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alimera Sciences stock
Who bought or sold Alimera Sciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Caligan Partners | 17M | $66M | 0% | Mar 2024 |
|
| Velan Capital Investment Management | 14M | $53M | 0% | Mar 2024 |
|
| Boothbay Fund Management | 3.2M | $13M | 0% | Mar 2024 |
|
| Altium Capital Management | 2.6M | $9.9M | -13% | Mar 2024 |
|
| Clearline Capital | 2.1M | $8.1M | -4% | Mar 2024 |
|
| AIGH Capital Management | 1.5M | $5.9M | -32% | Mar 2024 |
|
| Vanguard Group | 1.0M | $4.1M | 61% | Mar 2024 |
|
| Morgan Stanley | 502k | $2.0M | -25% | Mar 2024 |
|
| BlackRock | 483k | $1.9M | 90235% | Mar 2024 |
|
| Geode Capital Management | 378k | $1.5M | 616% | Mar 2024 |
|
| Ancora Advisors | 235k | $915k | 100% | Mar 2024 |
|
| Bank Of Montreal | 188k | $758k | 51% | Mar 2024 |
|
| Bridgeway Capital Management | 139k | $543k | 596% | Mar 2024 |
|
| Millennium Management | 126k | $492k | 289% | Mar 2024 |
|
| Susquehanna International | 107k | $418k | 100% | Mar 2024 |
|
| Marshall Wace | 85k | $333k | 100% | Mar 2024 |
|
| Northern Trust | 73k | $286k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 72k | $280k | 100% | Mar 2024 |
|
| Citigroup | 61k | $240k | 99% | Mar 2024 |
|
| Qube Research & Technologies | 47k | $182k | 100% | Mar 2024 |
|
| Hillsdale Investment Management | 43k | $169k | 100% | Mar 2024 |
|
| Citadel Advisors | 29k | $113k | 45% | Mar 2024 |
|
| Leucadia National Corporation | 26k | $102k | 102% | Mar 2024 |
|
| Hrt Financial | 26k | $99k | 100% | Mar 2024 |
|
| Bank of America Corporation | 24k | $92k | 13% | Mar 2024 |
|
| Jpmorgan Chase & Co | 22k | $86k | 36187% | Mar 2024 |
|
| Fifth Lane Capital | 21k | $83k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 10k | $40k | -74% | Mar 2024 |
|
| Advisor Group Holdings | 4.1k | $16k | 0% | Mar 2024 |
|
| Tower Research Capital | 944.00 | $3.7k | -92% | Mar 2024 |
|
| Steward Partners Investment Advisory | 666.00 | $2.6k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 287.00 | $1.1k | 2% | Mar 2024 |
|
| Syntax Research | 80.00 | $312.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 22.00 | $0 | 0% | Mar 2024 |
|
| Brian McDonald | 14.00 | $55.000400 | 0% | Mar 2024 |
|
Who sold out of Alimera Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Worth Venture Partners | Dec 2023 | 557k | $2.4M |
| Healthcare Of Ontario Pension Plan Trust Fund | Sep 2023 | 250k | $775k |
| HighTower Advisors | Dec 2023 | 25k | $108k |
| Acadian Asset Management | Sep 2023 | 7.7k | $23k |
| Focused Wealth Management | Dec 2023 | 66.00 | $285.001200 |